Get the Stockscreener App
3.21
2.79%
-0.09
Rocket Pharmaceuticals Inc stock is traded at $3.21, with a volume of 620.78K.
It is down -2.79% in the last 24 hours and down -7.56% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.30
Open:
$3.23
24h Volume:
620.78K
Relative Volume:
0.18
Market Cap:
$346.91M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.1673
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-0.69%
1M Performance:
-7.56%
6M Performance:
-51.51%
1Y Performance:
-79.53%
1-Day Range:
$3.17
$3.29
1-Week Range:
$3.01
$3.3686
52-Week Range:
$2.19
$15.95
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.215 | 357.13M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.25 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
708.62 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.26 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
896.70 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
375.07 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Can Rocket Pharmaceuticals Inc. stock deliver strong Q4 earningsJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell off2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Rocket Pharmaceuticals Inc. stock withstand economic slowdownJobs Report & Smart Swing Trading Alerts - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
Rocket Pharmaceuticals Inc Stock Analysis and ForecastBear Market Strategies & Plan Every Trade With Controlled Risk - earlytimes.in
Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Published on: 2025-11-13 02:15:05 - newser.com
Long term hold vs stop loss in Rocket Pharmaceuticals Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc.Weekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movementWeekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Risk adjusted return profile for Rocket Pharmaceuticals Inc. analyzedTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Published on: 2025-11-12 21:03:45 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growthJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionInsider Buying & Low Risk Entry Point Guides - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock benefits from tech adoptionJuly 2025 Outlook & Free Safe Capital Growth Stock Tips - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued historicallySell Signal & Capital Efficiency Focused Ideas - newser.com
What’s next for Rocket Pharmaceuticals Inc. stock priceMarket Activity Recap & Proven Capital Preservation Tips - newser.com
Published on: 2025-11-10 20:33:18 - newser.com
[Form 4] ROCKET PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts HNW investorsJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity WarrantBear Alert & Fast Moving Stock Trade Plans - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationPortfolio Value Report & Low Drawdown Momentum Ideas - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresCPI Data & Accurate Technical Buy Alerts - newser.com
Published on: 2025-11-10 02:19:46 - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecastingWeekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts wealthy investorsJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reportsJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Detecting support and resistance levels for Rocket Pharmaceuticals Inc.2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):